-
At Index Ventures, we have modelled the early stage development process (up to proof of clinical concept) on the presumption that the majority of the risk in a discovery programme is not only unknown but it also unknowable (ahead of testing in man).
FORBES: Are We The Problem? The Role Of Poor Decision-Making In Stifling Drug Development
-
On the other, they need to maintain profitability and limit risk, and traditionally, reaching these populations has required the development of costly infrastructure with little guarantee of return on investment.
FORBES: How Tech Can Help Financial Firms Reach The Underbanked
-
The researchers classified the embryos as low, medium or high risk of chromosome abnormalities based on their development at certain key points.
BBC: IVF 'may be boosted by time-lapse embryo imaging'
-
This more collaborative model is being applied to the high-risk innovative early stages of drug discovery, with companies taking on the highly expensive later stage development.
BBC: Falling drug breakthroughs 'a myth'
-
Yet, the need to fundraise also runs the risk of building a board that is focused only on numbers and not the governance or long term development of the organization.
FORBES: Building Successful Non-Profit Boards
-
Provide technical support and contribute to the substantive development of the field of Disaster Risk Reduction (DRR) and Education, with a strong focus on prevention, preparedness, coping skills and resilience, as an important contribution to education for sustainable development (ESD) and the UN Decade of Education for Sustainable development (DESD).
UNESCO: Vacancy : Programme Specialist (20/6/2011) (ED 005 - (P5))